Preface |
|
vii | |
|
|
ix | |
Acknowledgments |
|
xi | |
|
PART 1 Background and Overview Topics |
|
|
1 | (12) |
|
An Ethics Primer for Institutional Review Boards |
|
|
3 | (1) |
|
Reflections of an Outsider |
|
|
4 | (2) |
|
A Unified Human-Research Protection Program |
|
|
6 | (1) |
|
A Shared Responsibility for Protecting Human Subjects |
|
|
7 | (1) |
|
A Brief History of Public Responsibility in Medicine and Research and Institutional Review Board Education |
|
|
8 | (1) |
|
The Institutional Review Board: Definition and Federal Oversight |
|
|
9 | (1) |
|
The Limits of Institutional Review Board Authority |
|
|
10 | (3) |
|
|
12 | (1) |
|
PART 2 Organizing the Office |
|
|
13 | (10) |
|
Administrative Reporting Structure for the Institutional Review Board |
|
|
15 | (1) |
|
Documentation, Policies, and Procedures |
|
|
16 | (1) |
|
Tracking Systems Using Information Technology |
|
|
17 | (1) |
|
|
18 | (1) |
|
|
19 | (1) |
|
Charging for Institutional Review Board Review |
|
|
20 | (3) |
|
|
22 | (1) |
|
PART 3 Organizing the Institutional Review Board Committee |
|
|
23 | (12) |
|
Reflections on Chairing an Institutional Review Board |
|
|
25 | (1) |
|
The Institutional Review Board Chair |
|
|
26 | (1) |
|
The Institutional Review Board Administrative Director |
|
|
27 | (1) |
|
|
28 | (1) |
|
Committee Size, Alternates, and Consultants |
|
|
29 | (1) |
|
Length, Frequency, and Time of Institutional Review Board Meetings |
|
|
30 | (1) |
|
Institutional Review Board Subcommittees |
|
|
31 | (1) |
|
Social Science vs. Biomedical Institutional Review Boards |
|
|
32 | (3) |
|
|
34 | (1) |
|
|
35 | (12) |
|
Exempt from Institutional Review Board Review |
|
|
37 | (1) |
|
Expedited Institutional Review Board Review |
|
|
38 | (2) |
|
Identifying Intent: Is This Project Research? |
|
|
40 | (2) |
|
Compassionate Use and Emergency Use Exemption |
|
|
42 | (2) |
|
Waiver of Consent in Emergency Medicine Research |
|
|
44 | (3) |
|
|
46 | (1) |
|
PART 5 Initial Protocol Review and the Full-Committee Meeting |
|
|
47 | (22) |
|
Overview of Initial Protocol Review |
|
|
49 | (1) |
|
Evaluating Study Design and Quality |
|
|
50 | (1) |
|
The Study Population: Women, Minorities, and Children |
|
|
51 | (1) |
|
Community Consultation to Assess and Minimize Group Harms |
|
|
52 | (1) |
|
Privacy and Confidentiality |
|
|
53 | (2) |
|
Recruitment of Research Subjects |
|
|
55 | (1) |
|
Advertisements for Research |
|
|
56 | (2) |
|
|
58 | (2) |
|
Provisions for Data Monitoring |
|
|
60 | (2) |
|
Conflict of Interest: Researchers |
|
|
62 | (1) |
|
Conflict of Interest: Recruitment Incentives |
|
|
63 | (1) |
|
Conflict of Interest: Institutional Review Boards |
|
|
64 | (1) |
|
Administrative Tasks Before Each Institutional Review Board Meeting |
|
|
65 | (1) |
|
Guidelines for Review, Discussion, and Voting |
|
|
66 | (1) |
|
Administrative Tasks After Each Institutional Review Board Meeting |
|
|
67 | (2) |
|
|
68 | (1) |
|
|
69 | (18) |
|
The Institutional Review Board's Role in Editing the Consent Document |
|
|
71 | (1) |
|
|
72 | (1) |
|
Exculpatory Language in Informed Consent Documents |
|
|
73 | (1) |
|
Requiring a Witness Signature on the Consent Form |
|
|
74 | (1) |
|
Deception of Research Subjects |
|
|
75 | (2) |
|
Research Without Consent or Documentation Thereof |
|
|
77 | (1) |
|
Selecting a Surrogate to Consent to Medical Research |
|
|
78 | (1) |
|
Research-Related Injuries |
|
|
79 | (2) |
|
Informing Subjects about Research Results |
|
|
81 | (1) |
|
Explaining the Costs of Research Participation |
|
|
82 | (1) |
|
Improving Informed Consent |
|
|
83 | (2) |
|
Informed Consent Evaluation Feedback Tool |
|
|
85 | (2) |
|
|
86 | (1) |
|
|
87 | (10) |
|
Revisions to Approved Study |
|
|
89 | (1) |
|
|
90 | (2) |
|
Institutional Review Board Review of Adverse Events |
|
|
92 | (1) |
|
Data and Safety Monitoring |
|
|
93 | (1) |
|
Noncompliance, Complaints, Deviations, Eligibility Exceptions |
|
|
94 | (1) |
|
Institutional Review Board Closure of Study Files |
|
|
95 | (2) |
|
|
96 | (1) |
|
PART 8 Administrative and Regulatory Issues |
|
|
97 | (26) |
|
|
99 | (1) |
|
Office for Human Research Protections Federalwide Assurance |
|
|
100 | (1) |
|
International Conference on Harmonisation |
|
|
101 | (2) |
|
|
103 | (1) |
|
Understanding the Food and Drug Administration's Investigational New Drug Process |
|
|
104 | (1) |
|
Differences Between Department of Health and Human Services and Food and Drug Administration Regulations |
|
|
105 | (1) |
|
Veterans Administration Research Guidelines |
|
|
106 | (2) |
|
|
108 | (1) |
|
Institutional Review Board Member Liability |
|
|
109 | (1) |
|
Certificates of Confidentiality |
|
|
110 | (1) |
|
Training Institutional Review Board Members |
|
|
111 | (1) |
|
|
112 | (1) |
|
Accreditation of Human Research Protection Programs |
|
|
113 | (1) |
|
Certification of Institutional Review Board Professionals |
|
|
114 | (1) |
|
Preparing for a Food and Drug Administration Audit |
|
|
115 | (2) |
|
Preparing for an Office of Human Research Protections Site Visit |
|
|
117 | (6) |
|
|
120 | (3) |
|
PART 9 Issues Based on Study Population |
|
|
123 | (18) |
|
Vulnerability in Research |
|
|
125 | (1) |
|
Research in Public Schools |
|
|
126 | (1) |
|
Phase I Clinical Trials in Healthy Adults |
|
|
127 | (1) |
|
Requiring Birth Control to Participate in Research |
|
|
128 | (1) |
|
Research Involving Fetuses and In Vitro Fertilization |
|
|
129 | (2) |
|
Research Involving Pregnant Women |
|
|
131 | (1) |
|
Research Involving Children |
|
|
132 | (2) |
|
Research Involving Adults with Decisional Impairment |
|
|
134 | (2) |
|
Regulatory Issues of Research Involving Prisoners |
|
|
136 | (2) |
|
Research Involving College Students |
|
|
138 | (3) |
|
|
140 | (1) |
|
PART 10 IRB Issues Based on Study Design or Category |
|
|
141 | (28) |
|
When Are Research Risks Reasonable in Relationship to Anticipated Benefits? |
|
|
143 | (1) |
|
Internet Research: A Brief Guide for Institutional Review Boards |
|
|
144 | (1) |
|
Qualitative Social Science Research |
|
|
145 | (2) |
|
|
147 | (2) |
|
|
149 | (1) |
|
Epidemiology/Public Health Research |
|
|
150 | (2) |
|
|
152 | (1) |
|
Research Involving a Medical Device |
|
|
153 | (2) |
|
|
155 | (1) |
|
Banking of Human Biological Materials for Research |
|
|
156 | (1) |
|
The Placebo-Controlled Clinical Trial |
|
|
157 | (2) |
|
Treatment-Withholding Studies in Psychiatry |
|
|
159 | (2) |
|
|
161 | (2) |
|
Research Involving Genetic Testing |
|
|
163 | (1) |
|
|
164 | (1) |
|
Alternative Medicine Research |
|
|
165 | (4) |
|
|
166 | (3) |
|
PART 11 Reference Material and Contact Information |
|
|
169 | (7) |
|
|
171 | (2) |
|
World Medical Association Declaration of Helsinki |
|
|
173 | (3) |
|
|
176 | |